Free quiz
Supplement Guides Mar 11, 2026 5 min read

Phosphatidylserine for Dogs

Phosphatidylserine (PS) is a phospholipid critical for neuronal membrane function. A peer-reviewed canine trial demonstrated significant improvement in cognitive dysfunction signs — one of the few supplements with direct evidence in dogs with dementia.

Supplement Guide 5 sources cited
Applicable Sizes
T
S
M
L
G
Related Conditions
Cognitive Decline Anxiety
Puppy Longevity Editorial Team Evidence-reviewed nutrition guide Reviewed Mar 2026

A Building Block of the Aging Brain

Phosphatidylserine (PS) is a phospholipid that constitutes 13-15% of the phospholipids in the mammalian cerebral cortex. It is concentrated in the inner leaflet of neuronal cell membranes, where it plays structural and signaling roles: supporting membrane fluidity, facilitating neurotransmitter release, and enabling receptor-mediated signal transduction.

As dogs age, brain phospholipid composition changes. PS levels in neuronal membranes decline, correlating with reduced synaptic density and impaired neurotransmission. This is part of the biological substrate of canine cognitive dysfunction (CCD) — the veterinary equivalent of Alzheimer’s-type dementia.

What the Research Shows

The DeNapoli trial is the cornerstone. A 2003 JAVMA study (DeNapoli et al.) is the most significant piece of evidence for PS in dogs. It was a randomized, double-blind, placebo-controlled trial in aged dogs with established cognitive dysfunction signs. Dogs receiving a PS-containing supplement for 60 days showed significant improvements in disorientation, social interaction, and house-training compared to controls.

Important context on the DeNapoli study:

  • The supplement contained PS as the primary active ingredient but also included Ginkgo biloba, vitamin E, and pyridoxine — making it difficult to attribute all improvement solely to PS
  • The effect sizes were clinically meaningful, with owners and veterinarians both reporting noticeable behavioral improvements
  • Improvements were most pronounced in social interaction and spatial orientation

The 2006 follow-up data. A study in Progress in Neuro-Psychopharmacology and Biological Psychiatry tested PS-enriched diet in aged beagles using standardized cognitive testing (not just owner questionnaires). PS-supplemented dogs performed significantly better on spatial memory tasks, supporting the idea that PS genuinely enhances cognitive function rather than simply changing owner perception.

A 2011 CVJ study evaluated Senilife (a commercial product containing PS, resveratrol, vitamin E, and pyridoxine) in aged dogs with cognitive dysfunction signs. Significant improvements were documented across multiple CCD domains over 60 days.

The mechanistic basis is solid. PS supplementation increases membrane fluidity, enhances acetylcholine release, and supports glucose metabolism in aging brain tissue. These are the exact processes that deteriorate in CCD.

The anxiety connection. PS has been shown to blunt cortisol response to stress in human studies. Veterinary data on PS for canine anxiety is limited, but the cortisol-modulating mechanism is relevant for dogs with age-related anxiety — a common comorbidity with cognitive decline.

Practical Application

When to Consider PS

  • Dogs showing early signs of cognitive dysfunction (disorientation, disrupted sleep-wake cycles, changes in social interaction, loss of house-training)
  • Senior dogs (8+ years, earlier for giant breeds) as a preventive cognitive support strategy
  • As part of a multi-modal cognitive support protocol

Dosing

  • Small dogs (<10 kg): 50-100 mg daily
  • Medium dogs (10-25 kg): 100-200 mg daily
  • Large dogs (>25 kg): 200-300 mg daily

The DeNapoli trial used approximately 2 mg/kg/day as part of a combination supplement. Most veterinary neurologists recommend starting at the lower range and assessing response over 30-60 days.

Combination Strategy

PS works best as part of a broader cognitive support approach:

Source and Form

PS is commercially available from soy lecithin or sunflower lecithin sources. Both are acceptable. Capsule or powder forms mixed into food are practical for dogs. The soy-derived form has the most clinical data, but sunflower-derived PS avoids soy allergen concerns.

Safety and Contraindications

PS has an excellent safety record in both human and veterinary use.

  • GI effects: Occasional mild GI upset at higher doses. Uncommon at recommended ranges.
  • Anticoagulant interaction: Theoretical concern at very high doses (PS may enhance heparin and warfarin activity). Clinically irrelevant at standard supplement doses.
  • No known drug-supplement interactions at recommended doses
  • Safe for long-term use: No accumulation toxicity concerns documented
  • Pregnancy/lactation: Insufficient data. Avoid out of caution.

Bottom Line

Phosphatidylserine is one of the few supplements with direct, controlled trial evidence showing improvement in canine cognitive dysfunction. The DeNapoli trial and subsequent studies provide genuine support for its use in aging dogs with cognitive decline. It is not a cure for CCD, but it is a well-tolerated, evidence-backed component of a cognitive support protocol that can meaningfully improve quality of life in senior dogs.

Related reads: SAM-e for Dogs, Acetyl-L-Carnitine for Dogs, Cognitive Decline, Senior Dog Cognitive Care Plan

Frequently Asked Questions

At what age should I start giving my dog phosphatidylserine? Most veterinary neurologists recommend considering cognitive support supplements starting at age 8-10 for medium and large dogs, or when early cognitive changes are first noticed. Giant breeds may benefit from starting at 6-7 years. Preventive use before overt signs appear is reasonable given the safety profile.

How quickly does phosphatidylserine work? The DeNapoli trial showed measurable improvements within 60 days of consistent supplementation. Some owners report behavioral changes such as improved recognition of family members, better sleep patterns, and reduced nighttime restlessness within 2-4 weeks, though individual response varies considerably. Giant breeds like Great Danes and Newfoundlands, which enter cognitive decline earlier, may show faster response times when started at the first signs of disorientation or behavioral changes.

Can phosphatidylserine reverse canine dementia? It does not reverse established neurodegenerative changes. What it can do is improve remaining neuronal function, enhance neurotransmitter release, and slow further decline. Earlier intervention tends to produce better results than starting after severe cognitive deterioration.

Is soy-based or sunflower-based PS better? Both sources provide the same active phospholipid molecule and are functionally equivalent for cognitive support. Soy-derived PS has more published clinical data behind it, including the DeNapoli trial that forms the core evidence base for canine use. Sunflower-derived PS avoids potential soy allergen concerns and is preferred for dogs with known food sensitivities, particularly breeds like Golden Retrievers and Labrador Retrievers that have higher rates of dietary hypersensitivity.

Can I give PS with prescription cognitive dysfunction drugs? Yes. PS is commonly used alongside selegiline (Anipryl), the only FDA-approved drug for canine cognitive dysfunction, and there are no known pharmacological interactions between the two. Many veterinary neurologists use both together as part of a multi-modal cognitive support strategy. The mechanisms are complementary rather than overlapping, as selegiline works through monoamine oxidase B inhibition while PS supports neuronal membrane integrity and neurotransmitter release.

References

Related Condition Guides

Related Breed Guides

Sources